Showing 9 of 9 results

Lim KK et al.
OBJECTIVES: The success of the Expanded Program on Immunization among children will greatly reduce the burden of illness and disability from vaccine preventable diseases. The aim of the study was to...
World Health Organization (WHO)
The 2010 TechNet21 Consultation was held in Kuala Lumpur from 30 November to 2 December 2010. This meeting provided “an opportunity for us (the participants) to join forces and define the VISION...
Syed Aljunid et al.
Pneumococcal disease is the leading cause of vaccine-preventable death in children younger than 5 years of age worldwide. The World Health Organization recommends pneumococcal conjugate vaccine as a...
Grant L Campbell et al.
The global incidence of JE is unknown because the intensity and quality of JE surveillance and the availability of diagnostic laboratory testing vary throughout the world. Countries that have...
Christine McNab, Tracey Goodman & Susan Wang
This report presents communication guidance and specific considerations for countries that plan to introduce human papillomavirus (HPV) vaccine into their national immunization programme. New vaccine...
Syed Aljunid et al.
This study assesses the cost-effectiveness of introducing pneumococcal polysaccharide and nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in the National Immunization...